CanSino Biologics Inc. (HKG:6185)
Hong Kong
· Delayed Price · Currency is HKD 29.84
-2.20 (-6.87%)
Apr 29, 2026, 4:08 PM HKT
CanSino Biologics Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 12,900 | 12,632 | 11,610 | 12,514 | 27,690 | 66,111 | Upgrade
|
| Market Cap Growth | 5.34% | 8.81% | -7.23% | -54.81% | -58.12% | -11.15% | Upgrade
|
| Enterprise Value | 11,392 | 11,140 | 10,302 | 10,611 | 23,868 | 58,920 | Upgrade
|
| Last Close Price | 32.04 | 34.92 | 31.50 | 23.55 | 66.75 | 177.89 | Upgrade
|
| PE Ratio | 261.75 | 407.26 | - | - | - | 28.13 | Upgrade
|
| Forward PE | 35.83 | 45.28 | - | - | - | 11.16 | Upgrade
|
| PS Ratio | 10.86 | 10.63 | 12.89 | 31.81 | 23.68 | 12.53 | Upgrade
|
| PB Ratio | 2.34 | 2.29 | 2.22 | 2.15 | 3.38 | 6.30 | Upgrade
|
| P/TBV Ratio | 2.43 | 2.38 | 2.28 | 2.21 | 3.75 | 6.89 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 63.60 | Upgrade
|
| P/OCF Ratio | 127.41 | 124.77 | - | - | - | 26.27 | Upgrade
|
| EV/Sales Ratio | 9.59 | 9.37 | 11.44 | 26.97 | 20.41 | 11.16 | Upgrade
|
| EV/EBITDA Ratio | 124.60 | 130.77 | - | - | - | 25.96 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 26.91 | Upgrade
|
| EV/FCF Ratio | -66.94 | - | - | - | - | 56.68 | Upgrade
|
| Debt / Equity Ratio | 0.26 | 0.26 | 0.41 | 0.51 | 0.37 | 0.16 | Upgrade
|
| Debt / EBITDA Ratio | 15.68 | 15.68 | - | - | - | 0.74 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 1.62 | Upgrade
|
| Net Debt / Equity Ratio | -0.27 | -0.27 | -0.24 | -0.27 | -0.45 | -0.75 | Upgrade
|
| Net Debt / EBITDA Ratio | -17.70 | -17.70 | 7.80 | 0.97 | 2.46 | -3.46 | Upgrade
|
| Net Debt / FCF Ratio | 8.86 | 8.86 | 1.91 | 0.94 | 1.11 | -7.57 | Upgrade
|
| Asset Turnover | 0.14 | 0.14 | 0.10 | 0.03 | 0.09 | 0.46 | Upgrade
|
| Inventory Turnover | 0.84 | 0.84 | 0.83 | 1.55 | 1.57 | 2.48 | Upgrade
|
| Quick Ratio | 3.32 | 3.32 | 2.36 | 1.86 | 2.33 | 2.78 | Upgrade
|
| Current Ratio | 3.67 | 3.67 | 2.54 | 2.02 | 2.64 | 3.25 | Upgrade
|
| Return on Equity (ROE) | 0.56% | 0.56% | -7.52% | -31.40% | -12.22% | 26.09% | Upgrade
|
| Return on Assets (ROA) | -0.73% | -0.73% | -2.52% | -10.36% | -8.03% | 11.97% | Upgrade
|
| Return on Invested Capital (ROIC) | -2.45% | -2.40% | -9.21% | -43.85% | -48.83% | 108.45% | Upgrade
|
| Return on Capital Employed (ROCE) | -1.40% | -1.40% | -5.60% | -25.50% | -17.50% | 19.80% | Upgrade
|
| Earnings Yield | 0.24% | 0.25% | -3.47% | -13.05% | -3.71% | 3.55% | Upgrade
|
| FCF Yield | -1.32% | -1.35% | -5.73% | -13.37% | -11.95% | 1.57% | Upgrade
|
| Dividend Yield | - | - | - | - | - | 0.55% | Upgrade
|
| Payout Ratio | 159.68% | 159.68% | - | - | - | 0.74% | Upgrade
|
| Buyback Yield / Dilution | -2.32% | -2.32% | -0.38% | 0.17% | 0.08% | -7.26% | Upgrade
|
| Total Shareholder Return | -2.32% | -2.32% | -0.38% | 0.17% | 0.08% | -6.70% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.